Financial Services Company

Healthcare Alpha Partners, LLC

6%

Funding Goal $2,000,000
Funding Raised So Far $60,000
Funding Commitments $50,000
Funding Remaining $1,890,000
Funding Type Common Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Company Overview

Healthcare Alpha Partners is an investment management firm that invests with a long-term view in healthcare stocks, specifically pharmaceuticals, biotechnology, and pharmaceutical services. We take a differentiated approach to traditional investors.

We are a long-biased (85% Long / 15% Short) investment management firm with a long-term view to healthcare investing (2-3 year holding period). On the long side, we identify high performing companies with a competitive moat, strong revenue growth and financials, and stable management teams. On the short side, we identify poorly performing companies with less competitive drugs / assets, mismanaged financials and capital structure, and underperforming management teams.

Healthcare Alpha Partners will invest in stocks that we deem successful irrespective of market or macro-economic conditions. We seek to invest in companies that are leaders in their areas of specialization with promising pharmaceutical assets, long-dated patent life, and continuous strengthening of its core business. Our value-oriented and event-driven strategy enables us to identify leading ("Go Long") and overvalued ("Go Short") companies within their healthcare sector.

We are looking for seed investors who can believe in us to get our investment strategy started. We are looking for partners who are willing to take a minority stake in our company and are interested in growing their capital long term. In return you will have a stake in our company and will reap a percent of the profits we make with your capital and subsequent capital from new investors.

What differentiates us from other investors? To name a few:

1. The Founder, Deo, has deep sector expertise in healthcare and finance with over 5 years of experience in pharmaceuticals and healthcare investment banking at Goldman Sachs. Deo completed his PhD in Pharmacology at Case Western and an MBA from MIT

2. We run a concentrated portfolio (10-15 companies) with a long-term investment horizon of 2-3 years

3. Utilize zero debt to minimize investment risk

4. Low operational cost to help run the fund efficiently

5. An opportunity to invest in cutting edge drugs that can help treat diseases

For questions email: IR@healthcarealphapartners.com

lock icon

Invest in Company

Sign up or log in now to unlock profile details and access financials, company documents, and invest in companies.

Investor Sign Up
Investor Log In

Business Summary

Company Age
Employees
Sub-Industry
Prior Year Revenue
Current Year Revenue
Next Year Revenue

Products/Services

Public Market Investing (Healthcare Stocks)

We are dedicated to finding the best healthcare companies to invest in long term. With the $2mm raised, we will use $250,000 per year for two years in efficiently running the day-to-day operations of the fund and we target to return to our investors 35-50% annually.

There will be 3 sources of value for seed capital providers:

1. Annual profits on the initial seed investment
2. Annual profits on post-seed capital (new investor capital)
3. Equity ownership in HAPartners which will grow over time. Seed capital provided at $2 per share could increase to over $23 in 10 years. So, a $10,000 seed investment at $2.00 per share (i.e., 5,000 shares) could become $115,300 in 10 years (i.e. at $23.06 per share)

Some key terms / notes:

1. Seed capital providers will have a 2-year lock-up to fully implement and develop the strategy. After 2 years, the lock-up period will be 1 year
2. Performance reports will be provided every quarter
3. All investors will have access to an investor portal

Management

Deo Tonade, PhD
Chief Investment Officer
Deo T......

The Founder, CEO & CIO, Deo T...... plans to leverage his 5+ years of experience in pharmaceuticals at CMC Pharmaceuticals and Medpace, and Healthcare Investment Banking at Goldman Sachs in identifying promising companies that are generating new treatments for pressing diseases such as Cancer, Diabetes, Alzheimer's disease, etc.

As an investment banker at Goldman Sachs, Deo worked on over $40 billion in healthcare transactions including M&A, and equity and debt financings. To name a few, Deo worked on the $14bn sale of Karuna Therapeutics to Bristol Myers Squibb, and the $10bn sale of Immunogen to AbbVie in 2023. At Medpace, Deo was a Project Manager and managed clinical trials (Phase I-III) for biotech companies in US and EU. At CMC Pharmaceuticals, Deo worked within R&D developing non-opioid combinations to help treat back pain.

Deo completed his in Pharmacology at Case Western, his MBA at MIT Sloan, his MPH at Indiana University, and his BS in Biology at Purdue University.

6%

Funding Goal $2,000,000
Funding Raised So Far $60,000
Funding Commitments $50,000
Funding Remaining $1,890,000
Funding Type Common Equity
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Documents

Contact

Healthcare Alpha Partners, LLC

New York, NY 10006, US

Top 10 Tips for Entrepreneurs Seeking Funding

Users who follow these tips increase their fundraising odds substantially.

  • Complete Your Funding Profile
    • Complete your funding profile with all sections filled, including your products and services, a complete management team with headshots, and slideshow with product images.
  • Complete a Business Plan (Optional)
    • Complete a Business Plan in EquityNet and refine your financial projections using the benchmarking alerts in the Business Plan Analysis report.
  • Upload Important Investment Documents
    • Upload and present any other important investment documents such as pitch decks, financial statements, and offering materials.
  • Use EquityNet Crowdcast
    • Use the EquityNet Crowdcast system to automatically email invitations to your contacts in order to build additional exposure for your company.
  • Construct Concise Introductory Messages
    • Construct and send a concise introductory message to investors, including primary reasons why they should want to invest such as KPIs, expected returns, and forecasted revenue.
  • Be Proactive in Messaging Investors
    • Be proactive in messaging many investors and include a simple way for them to connect with you for a web meeting or call, such as a Calendly link.
  • Use the Activity System
    • Use the Activity system to track interested investors, and send prompt follow-up messages to investors who viewed your profile or showed interest.
  • Prepare for Due Diligence
    • Prepare for due diligence questions by interested investors and use your Business Plan and investment documents to satisfy such requests.
  • Keep Your Funding Profile Updated
    • Keep your funding profile updated with new funding raised/committed and message interested investors with any new milestones achieved.
  • Do Not Respond to Unknown Investors
    • Do not respond to or engage any parties outside of EquityNet that are not listed as approved investors (this may happen due to your public profile and LinkedIn connections).